| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 28 | 2024 | 1099 | 3.490 |
Why?
|
| Heart Defects, Congenital | 28 | 2022 | 1804 | 2.670 |
Why?
|
| Heart Transplantation | 20 | 2022 | 854 | 2.370 |
Why?
|
| Pulmonary Artery | 11 | 2022 | 439 | 2.330 |
Why?
|
| Extracorporeal Membrane Oxygenation | 26 | 2016 | 621 | 2.240 |
Why?
|
| Truncus Arteriosus, Persistent | 4 | 2021 | 17 | 2.230 |
Why?
|
| Reoperation | 15 | 2021 | 819 | 2.040 |
Why?
|
| Postoperative Complications | 14 | 2024 | 3017 | 1.580 |
Why?
|
| Heart-Assist Devices | 20 | 2022 | 1026 | 1.480 |
Why?
|
| Infant | 68 | 2024 | 12355 | 1.480 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2020 | 274 | 1.340 |
Why?
|
| Aortic Coarctation | 3 | 2021 | 105 | 1.250 |
Why?
|
| Aorta, Thoracic | 6 | 2021 | 520 | 1.160 |
Why?
|
| Retrospective Studies | 66 | 2024 | 16041 | 1.140 |
Why?
|
| Heart Valve Prosthesis | 4 | 2020 | 293 | 1.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2020 | 429 | 1.110 |
Why?
|
| Norwood Procedures | 6 | 2020 | 100 | 1.090 |
Why?
|
| Infant, Newborn | 45 | 2024 | 8109 | 1.070 |
Why?
|
| Aortic Stenosis, Supravalvular | 2 | 2020 | 19 | 1.060 |
Why?
|
| Scimitar Syndrome | 3 | 2021 | 51 | 1.030 |
Why?
|
| Treatment Outcome | 48 | 2024 | 12123 | 0.990 |
Why?
|
| Bioprosthesis | 3 | 2015 | 111 | 0.990 |
Why?
|
| Child, Preschool | 54 | 2024 | 13881 | 0.950 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2015 | 85 | 0.950 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 2024 | 4 | 0.930 |
Why?
|
| Truncus Arteriosus | 2 | 2021 | 13 | 0.910 |
Why?
|
| Heart Septal Defects | 2 | 2022 | 40 | 0.850 |
Why?
|
| Vascular Surgical Procedures | 4 | 2021 | 565 | 0.830 |
Why?
|
| Follow-Up Studies | 23 | 2024 | 5048 | 0.810 |
Why?
|
| Child | 55 | 2024 | 24226 | 0.800 |
Why?
|
| Hypoplastic Left Heart Syndrome | 8 | 2020 | 252 | 0.780 |
Why?
|
| Heart Ventricles | 7 | 2021 | 762 | 0.780 |
Why?
|
| Heart Valves | 2 | 2020 | 51 | 0.770 |
Why?
|
| Airway Extubation | 3 | 2018 | 67 | 0.760 |
Why?
|
| Humans | 111 | 2024 | 123075 | 0.750 |
Why?
|
| Postoperative Care | 5 | 2018 | 295 | 0.740 |
Why?
|
| Male | 79 | 2024 | 60082 | 0.730 |
Why?
|
| Vena Cava, Inferior | 2 | 2013 | 100 | 0.700 |
Why?
|
| Heart Valve Diseases | 2 | 2020 | 166 | 0.690 |
Why?
|
| Survival Rate | 12 | 2020 | 1997 | 0.670 |
Why?
|
| Coronary Vessels | 2 | 2020 | 526 | 0.670 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2020 | 343 | 0.660 |
Why?
|
| Female | 74 | 2024 | 65532 | 0.650 |
Why?
|
| Aneurysm | 2 | 2012 | 88 | 0.650 |
Why?
|
| Heart Failure | 13 | 2022 | 2127 | 0.650 |
Why?
|
| Mitral Valve | 2 | 2020 | 246 | 0.640 |
Why?
|
| Abnormalities, Multiple | 3 | 2012 | 962 | 0.640 |
Why?
|
| Aortic Diseases | 1 | 2021 | 197 | 0.640 |
Why?
|
| Tetralogy of Fallot | 5 | 2021 | 161 | 0.640 |
Why?
|
| Prostheses and Implants | 2 | 2022 | 150 | 0.630 |
Why?
|
| Time Factors | 22 | 2024 | 6222 | 0.630 |
Why?
|
| Arkansas | 10 | 2015 | 58 | 0.590 |
Why?
|
| Intraoperative Complications | 3 | 2017 | 175 | 0.590 |
Why?
|
| Pulmonary Valve Insufficiency | 2 | 2015 | 39 | 0.580 |
Why?
|
| Surgical Sponges | 1 | 2017 | 1 | 0.580 |
Why?
|
| Kaolin | 1 | 2017 | 2 | 0.580 |
Why?
|
| Phrenic Nerve | 1 | 2017 | 11 | 0.570 |
Why?
|
| Hemostatic Techniques | 1 | 2017 | 32 | 0.560 |
Why?
|
| Magnets | 1 | 2017 | 22 | 0.560 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2017 | 33 | 0.560 |
Why?
|
| Hemodynamics | 5 | 2018 | 845 | 0.550 |
Why?
|
| Pulmonary Valve | 2 | 2015 | 94 | 0.540 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 147 | 0.540 |
Why?
|
| Thrombosis | 1 | 2021 | 520 | 0.530 |
Why?
|
| Double Outlet Right Ventricle | 2 | 2015 | 21 | 0.520 |
Why?
|
| Fontan Procedure | 5 | 2010 | 182 | 0.490 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 291 | 0.480 |
Why?
|
| Subclavian Artery | 2 | 2012 | 71 | 0.480 |
Why?
|
| Polytetrafluoroethylene | 1 | 2015 | 80 | 0.480 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 360 | 0.480 |
Why?
|
| Adolescent | 31 | 2022 | 19097 | 0.470 |
Why?
|
| Vascular Malformations | 2 | 2012 | 81 | 0.460 |
Why?
|
| Transportation of Patients | 2 | 2011 | 55 | 0.450 |
Why?
|
| Forecasting | 1 | 2015 | 354 | 0.440 |
Why?
|
| Heart Diseases | 5 | 2013 | 482 | 0.440 |
Why?
|
| Pulmonary Veins | 3 | 2024 | 162 | 0.440 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2011 | 121 | 0.440 |
Why?
|
| Coronary Circulation | 7 | 2019 | 209 | 0.430 |
Why?
|
| Patient Transfer | 2 | 2011 | 101 | 0.420 |
Why?
|
| Prosthesis Design | 5 | 2020 | 672 | 0.420 |
Why?
|
| Aorta | 3 | 2021 | 542 | 0.410 |
Why?
|
| Shock, Septic | 2 | 2011 | 146 | 0.400 |
Why?
|
| Aortic Arch Syndromes | 1 | 2012 | 11 | 0.400 |
Why?
|
| Heart Rupture | 1 | 2011 | 3 | 0.390 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2012 | 51 | 0.390 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2011 | 13 | 0.390 |
Why?
|
| Atrial Septum | 1 | 2011 | 10 | 0.390 |
Why?
|
| Amiodarone | 1 | 2011 | 45 | 0.380 |
Why?
|
| Equipment Design | 6 | 2017 | 601 | 0.370 |
Why?
|
| Replantation | 2 | 2022 | 54 | 0.370 |
Why?
|
| Deglutition Disorders | 1 | 2012 | 126 | 0.350 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2011 | 219 | 0.340 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2020 | 138 | 0.310 |
Why?
|
| Young Adult | 11 | 2022 | 8838 | 0.290 |
Why?
|
| Respiration, Artificial | 5 | 2015 | 455 | 0.290 |
Why?
|
| Age Factors | 8 | 2021 | 2803 | 0.290 |
Why?
|
| Palliative Care | 5 | 2020 | 428 | 0.290 |
Why?
|
| Vena Cava, Superior | 1 | 2007 | 55 | 0.280 |
Why?
|
| Ebstein Anomaly | 1 | 2007 | 26 | 0.270 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2012 | 796 | 0.270 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2020 | 50 | 0.270 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2007 | 63 | 0.260 |
Why?
|
| Cohort Studies | 13 | 2018 | 4705 | 0.260 |
Why?
|
| Risk Factors | 15 | 2020 | 10016 | 0.260 |
Why?
|
| Foreign Bodies | 1 | 2007 | 104 | 0.260 |
Why?
|
| Respiratory Insufficiency | 3 | 2013 | 231 | 0.250 |
Why?
|
| Hospital Mortality | 10 | 2020 | 1010 | 0.240 |
Why?
|
| Ultrasonography | 5 | 2015 | 940 | 0.240 |
Why?
|
| Thoracic Surgery | 1 | 2007 | 157 | 0.240 |
Why?
|
| Biliary Atresia | 1 | 2007 | 186 | 0.240 |
Why?
|
| Proportional Hazards Models | 4 | 2016 | 1305 | 0.230 |
Why?
|
| Risk Assessment | 9 | 2015 | 3317 | 0.230 |
Why?
|
| Heart Arrest | 3 | 2014 | 341 | 0.230 |
Why?
|
| Incidence | 6 | 2018 | 3044 | 0.230 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2024 | 19 | 0.230 |
Why?
|
| Prosthesis Implantation | 1 | 2005 | 143 | 0.230 |
Why?
|
| Device Removal | 2 | 2022 | 222 | 0.210 |
Why?
|
| Infant, Premature | 1 | 2008 | 800 | 0.210 |
Why?
|
| Azygos Vein | 2 | 2013 | 8 | 0.210 |
Why?
|
| Angioplasty, Balloon | 1 | 2024 | 161 | 0.210 |
Why?
|
| Cause of Death | 3 | 2014 | 463 | 0.200 |
Why?
|
| Pulmonary Atresia | 3 | 2019 | 48 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2012 | 102 | 0.200 |
Why?
|
| Prosthesis Failure | 2 | 2015 | 159 | 0.200 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 169 | 0.190 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 1004 | 0.190 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2013 | 214 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2012 | 238 | 0.190 |
Why?
|
| Cardiotonic Agents | 2 | 2018 | 135 | 0.190 |
Why?
|
| Norepinephrine | 3 | 2007 | 175 | 0.190 |
Why?
|
| Factor VIIa | 1 | 2020 | 24 | 0.180 |
Why?
|
| Arterial Switch Operation | 1 | 2020 | 22 | 0.180 |
Why?
|
| Tracheal Stenosis | 1 | 2020 | 31 | 0.180 |
Why?
|
| Brain Infarction | 1 | 2020 | 30 | 0.170 |
Why?
|
| Myxoma | 1 | 2020 | 28 | 0.170 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 71 | 0.170 |
Why?
|
| Cattle | 1 | 2021 | 558 | 0.170 |
Why?
|
| Heart Atria | 1 | 2022 | 313 | 0.170 |
Why?
|
| Heart | 4 | 2006 | 723 | 0.170 |
Why?
|
| Discrete Subaortic Stenosis | 1 | 2019 | 7 | 0.170 |
Why?
|
| Vascular Ring | 1 | 2019 | 6 | 0.170 |
Why?
|
| Aortic Valve | 2 | 2020 | 435 | 0.170 |
Why?
|
| HLA Antigens | 2 | 2013 | 243 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 100 | 0.160 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 27 | 0.160 |
Why?
|
| Cyanosis | 2 | 2012 | 41 | 0.160 |
Why?
|
| Chromosome Deletion | 2 | 2012 | 638 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2004 | 375 | 0.160 |
Why?
|
| Echocardiography | 6 | 2020 | 1049 | 0.160 |
Why?
|
| Actuarial Analysis | 2 | 2016 | 30 | 0.160 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2015 | 156 | 0.150 |
Why?
|
| Drug Dosage Calculations | 1 | 2018 | 19 | 0.150 |
Why?
|
| Stents | 1 | 2024 | 873 | 0.150 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 203 | 0.140 |
Why?
|
| Hospitals, Pediatric | 4 | 2012 | 780 | 0.140 |
Why?
|
| Cardiology | 2 | 2021 | 473 | 0.140 |
Why?
|
| Waiting Lists | 2 | 2016 | 225 | 0.140 |
Why?
|
| Blood Substitutes | 2 | 2007 | 6 | 0.140 |
Why?
|
| Ventricular Fibrillation | 2 | 2007 | 51 | 0.140 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 334 | 0.130 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 260 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 372 | 0.130 |
Why?
|
| Hemodilution | 2 | 2006 | 15 | 0.130 |
Why?
|
| Databases, Factual | 3 | 2016 | 1172 | 0.130 |
Why?
|
| Pulmonary Circulation | 2 | 2008 | 121 | 0.130 |
Why?
|
| North America | 3 | 2011 | 239 | 0.130 |
Why?
|
| Gastrostomy | 3 | 2011 | 84 | 0.130 |
Why?
|
| Texas | 2 | 2020 | 3563 | 0.120 |
Why?
|
| Odds Ratio | 3 | 2018 | 1245 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 46 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 872 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 280 | 0.120 |
Why?
|
| Recurrence | 2 | 2016 | 1419 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2012 | 459 | 0.110 |
Why?
|
| Adult | 11 | 2022 | 29014 | 0.110 |
Why?
|
| Respiratory Tract Fistula | 1 | 2013 | 15 | 0.110 |
Why?
|
| Length of Stay | 7 | 2018 | 1289 | 0.110 |
Why?
|
| Bronchial Fistula | 1 | 2013 | 22 | 0.110 |
Why?
|
| Pleural Diseases | 1 | 2013 | 29 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 87 | 0.110 |
Why?
|
| Cardiac Output, Low | 1 | 2013 | 66 | 0.110 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 171 | 0.110 |
Why?
|
| Atrial Appendage | 1 | 2013 | 43 | 0.110 |
Why?
|
| Isoantibodies | 1 | 2013 | 70 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 586 | 0.110 |
Why?
|
| Ventilator Weaning | 1 | 2013 | 23 | 0.110 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2012 | 133 | 0.110 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 41 | 0.100 |
Why?
|
| Heart Septum | 1 | 2012 | 55 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 317 | 0.100 |
Why?
|
| Positive-Pressure Respiration | 1 | 2013 | 83 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2013 | 311 | 0.100 |
Why?
|
| Coronary Artery Bypass | 1 | 2016 | 489 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2012 | 312 | 0.100 |
Why?
|
| Coronary Angiography | 2 | 2019 | 420 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1412 | 0.100 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2012 | 3 | 0.100 |
Why?
|
| Radiography | 2 | 2011 | 822 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2011 | 350 | 0.100 |
Why?
|
| Heart Block | 1 | 2012 | 40 | 0.100 |
Why?
|
| Diverticulum | 1 | 2012 | 28 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 31 | 0.100 |
Why?
|
| Ventricular Function | 1 | 2012 | 92 | 0.100 |
Why?
|
| Career Choice | 1 | 2013 | 144 | 0.100 |
Why?
|
| DiGeorge Syndrome | 1 | 2012 | 79 | 0.100 |
Why?
|
| Pediatrics | 1 | 2021 | 1141 | 0.100 |
Why?
|
| Aortography | 1 | 2012 | 200 | 0.100 |
Why?
|
| Hemolysis | 1 | 2011 | 105 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 1876 | 0.090 |
Why?
|
| Hepacivirus | 1 | 2013 | 241 | 0.090 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2011 | 114 | 0.090 |
Why?
|
| Ambulances | 1 | 2011 | 23 | 0.090 |
Why?
|
| Air Ambulances | 1 | 2011 | 25 | 0.090 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2010 | 8 | 0.090 |
Why?
|
| Equipment Safety | 1 | 2011 | 37 | 0.090 |
Why?
|
| Assisted Circulation | 1 | 2011 | 34 | 0.090 |
Why?
|
| Germany | 1 | 2011 | 66 | 0.090 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 111 | 0.090 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2011 | 40 | 0.090 |
Why?
|
| Myocardial Reperfusion | 2 | 2007 | 73 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 150 | 0.090 |
Why?
|
| Brain | 2 | 2020 | 2962 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2011 | 301 | 0.090 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 29 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 423 | 0.090 |
Why?
|
| Heart Arrest, Induced | 1 | 2010 | 73 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 198 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2011 | 197 | 0.090 |
Why?
|
| Heparin | 2 | 2008 | 227 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 204 | 0.090 |
Why?
|
| Lactates | 1 | 2010 | 93 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 280 | 0.080 |
Why?
|
| Myocarditis | 1 | 2011 | 119 | 0.080 |
Why?
|
| Catheterization | 2 | 2011 | 235 | 0.080 |
Why?
|
| Expectorants | 1 | 2009 | 7 | 0.080 |
Why?
|
| Middle Aged | 5 | 2017 | 25995 | 0.080 |
Why?
|
| Deoxyribonucleases | 1 | 2009 | 26 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 2109 | 0.080 |
Why?
|
| Pulmonary Atelectasis | 1 | 2009 | 14 | 0.080 |
Why?
|
| Lymphopenia | 1 | 2009 | 36 | 0.080 |
Why?
|
| Syndrome | 2 | 2013 | 1115 | 0.080 |
Why?
|
| Cineangiography | 1 | 2008 | 15 | 0.080 |
Why?
|
| Survival Analysis | 4 | 2016 | 1473 | 0.080 |
Why?
|
| Logistic Models | 2 | 2011 | 1798 | 0.080 |
Why?
|
| Pipecolic Acids | 1 | 2008 | 6 | 0.080 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2013 | 448 | 0.080 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 323 | 0.080 |
Why?
|
| Stroke | 2 | 2013 | 955 | 0.080 |
Why?
|
| Ketamine | 1 | 2012 | 214 | 0.080 |
Why?
|
| Cerebral Hemorrhage | 1 | 2009 | 144 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2009 | 233 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2008 | 189 | 0.070 |
Why?
|
| Risk | 2 | 2013 | 745 | 0.070 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2007 | 43 | 0.070 |
Why?
|
| Catheters | 2 | 2022 | 89 | 0.070 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 93 | 0.070 |
Why?
|
| Critical Care | 2 | 2012 | 648 | 0.070 |
Why?
|
| Histocompatibility Testing | 1 | 2007 | 148 | 0.070 |
Why?
|
| Feeding Methods | 1 | 2007 | 37 | 0.070 |
Why?
|
| Animals | 8 | 2021 | 33791 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 2055 | 0.070 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2007 | 72 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2011 | 486 | 0.070 |
Why?
|
| Compartment Syndromes | 1 | 2007 | 31 | 0.070 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2006 | 5 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 525 | 0.070 |
Why?
|
| Receptor, Endothelin A | 1 | 2006 | 12 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2008 | 581 | 0.070 |
Why?
|
| Hemofiltration | 1 | 2006 | 13 | 0.070 |
Why?
|
| Kidney | 1 | 2013 | 1335 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 228 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 1000 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2009 | 391 | 0.070 |
Why?
|
| Abdomen | 1 | 2007 | 130 | 0.070 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2007 | 144 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 239 | 0.070 |
Why?
|
| Shock, Cardiogenic | 2 | 2022 | 187 | 0.070 |
Why?
|
| Vocal Cord Paralysis | 1 | 2007 | 68 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2012 | 762 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 864 | 0.060 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 87 | 0.060 |
Why?
|
| Guinea Pigs | 4 | 2007 | 167 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 3544 | 0.060 |
Why?
|
| Atrial Flutter | 1 | 2005 | 32 | 0.060 |
Why?
|
| Organ Preservation | 1 | 2005 | 36 | 0.060 |
Why?
|
| Sympathetic Nervous System | 1 | 2005 | 62 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2009 | 548 | 0.060 |
Why?
|
| Allied Health Personnel | 1 | 2006 | 74 | 0.060 |
Why?
|
| Inflammation | 1 | 2012 | 1403 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2005 | 82 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2005 | 56 | 0.060 |
Why?
|
| Decision Making | 1 | 2010 | 651 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2005 | 86 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2021 | 437 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2011 | 767 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2011 | 842 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1084 | 0.060 |
Why?
|
| Angiography | 1 | 2024 | 215 | 0.050 |
Why?
|
| Chordae Tendineae | 1 | 2003 | 7 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 270 | 0.050 |
Why?
|
| Emergencies | 1 | 2004 | 174 | 0.050 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hypoxia | 1 | 2004 | 248 | 0.050 |
Why?
|
| Aged | 3 | 2017 | 19095 | 0.050 |
Why?
|
| Hypothermia, Induced | 2 | 2020 | 161 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2013 | 1158 | 0.050 |
Why?
|
| Critical Illness | 3 | 2012 | 591 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2020 | 1389 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 698 | 0.050 |
Why?
|
| Heart Aneurysm | 1 | 2002 | 38 | 0.050 |
Why?
|
| Postoperative Period | 2 | 2014 | 330 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 1386 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 3074 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2013 | 335 | 0.050 |
Why?
|
| Aneurysm, False | 1 | 2002 | 102 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 406 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 2848 | 0.040 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 25 | 0.040 |
Why?
|
| Facial Paralysis | 1 | 2020 | 36 | 0.040 |
Why?
|
| Sepsis | 1 | 2004 | 477 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2007 | 966 | 0.040 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2012 | 133 | 0.040 |
Why?
|
| Hemorrhage | 2 | 2014 | 458 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 202 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 332 | 0.040 |
Why?
|
| Biomarkers | 3 | 2015 | 2944 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 724 | 0.040 |
Why?
|
| Trachea | 1 | 2020 | 201 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2019 | 108 | 0.040 |
Why?
|
| Nordefrin | 1 | 2018 | 2 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2014 | 483 | 0.040 |
Why?
|
| Milrinone | 1 | 2018 | 30 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 606 | 0.040 |
Why?
|
| Peritoneal Dialysis | 2 | 2012 | 118 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 92 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2010 | 450 | 0.040 |
Why?
|
| Markov Chains | 1 | 2018 | 83 | 0.040 |
Why?
|
| Warfarin | 2 | 2008 | 118 | 0.040 |
Why?
|
| Graft Rejection | 2 | 2013 | 582 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 622 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2012 | 470 | 0.030 |
Why?
|
| Epinephrine | 1 | 2018 | 175 | 0.030 |
Why?
|
| Comorbidity | 2 | 2013 | 1496 | 0.030 |
Why?
|
| United States | 3 | 2020 | 10652 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2018 | 278 | 0.030 |
Why?
|
| Perfusion | 2 | 2009 | 198 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2009 | 47 | 0.030 |
Why?
|
| Dopamine | 1 | 2018 | 282 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 1138 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1008 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 265 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 729 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 860 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 630 | 0.030 |
Why?
|
| Dogs | 2 | 2006 | 765 | 0.030 |
Why?
|
| Random Allocation | 2 | 2005 | 428 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 152 | 0.030 |
Why?
|
| Prognosis | 2 | 2014 | 4513 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2014 | 41 | 0.030 |
Why?
|
| Sternotomy | 1 | 2014 | 42 | 0.030 |
Why?
|
| Berlin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Autopsy | 1 | 2014 | 110 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2014 | 0.030 |
Why?
|
| Compassionate Use Trials | 1 | 2013 | 14 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1463 | 0.030 |
Why?
|
| Thoracic Injuries | 1 | 2013 | 91 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 100 | 0.030 |
Why?
|
| Hyperbilirubinemia | 1 | 2013 | 41 | 0.030 |
Why?
|
| Body Size | 1 | 2013 | 53 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 77 | 0.030 |
Why?
|
| Cardiac Catheterization | 2 | 2010 | 631 | 0.030 |
Why?
|
| Shock | 1 | 2013 | 90 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 56 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 252 | 0.020 |
Why?
|
| Centrifugation | 1 | 2011 | 25 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 140 | 0.020 |
Why?
|
| Mortality | 1 | 2013 | 228 | 0.020 |
Why?
|
| Heart Rate | 2 | 2005 | 586 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2011 | 31 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 2010 | 34 | 0.020 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2010 | 3 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 83 | 0.020 |
Why?
|
| Myocardium | 2 | 2006 | 985 | 0.020 |
Why?
|
| Fundoplication | 1 | 2011 | 66 | 0.020 |
Why?
|
| Ductus Arteriosus | 1 | 2011 | 63 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 152 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2012 | 254 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 76 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 669 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2013 | 195 | 0.020 |
Why?
|
| Laparotomy | 1 | 2011 | 135 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 294 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 1238 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6027 | 0.020 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2009 | 20 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2010 | 215 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 409 | 0.020 |
Why?
|
| Phenoxybenzamine | 1 | 2009 | 12 | 0.020 |
Why?
|
| Child Development | 1 | 2012 | 260 | 0.020 |
Why?
|
| Bacteremia | 1 | 2013 | 404 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2009 | 29 | 0.020 |
Why?
|
| Sternum | 1 | 2009 | 53 | 0.020 |
Why?
|
| Nutritional Support | 1 | 2009 | 51 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2009 | 28 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2009 | 169 | 0.020 |
Why?
|
| Home Care Services | 1 | 2009 | 67 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2010 | 111 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 150 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2013 | 363 | 0.020 |
Why?
|
| Child Nutrition Disorders | 1 | 2009 | 76 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2009 | 146 | 0.020 |
Why?
|
| Heparin Antagonists | 1 | 2008 | 5 | 0.020 |
Why?
|
| Protamines | 1 | 2008 | 13 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 473 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 478 | 0.020 |
Why?
|
| Dipyridamole | 1 | 2008 | 29 | 0.020 |
Why?
|
| Antithrombin III | 1 | 2008 | 25 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2008 | 23 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2008 | 42 | 0.020 |
Why?
|
| Program Development | 1 | 2009 | 189 | 0.020 |
Why?
|
| Weight Gain | 1 | 2011 | 401 | 0.020 |
Why?
|
| Thrombin | 1 | 2008 | 60 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1590 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2404 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 752 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 489 | 0.020 |
Why?
|
| Drainage | 1 | 2009 | 257 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 253 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 555 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 1155 | 0.020 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2007 | 52 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3239 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 537 | 0.020 |
Why?
|
| Liposomes | 1 | 2007 | 169 | 0.020 |
Why?
|
| Endothelin A Receptor Antagonists | 1 | 2006 | 9 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 373 | 0.020 |
Why?
|
| Aspirin | 1 | 2008 | 224 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 303 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2006 | 43 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2008 | 259 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 1000 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 1284 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 258 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 478 | 0.020 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2005 | 7 | 0.020 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2005 | 12 | 0.020 |
Why?
|
| Tromethamine | 1 | 2005 | 9 | 0.020 |
Why?
|
| Bradykinin | 1 | 2005 | 57 | 0.020 |
Why?
|
| Reperfusion | 1 | 2005 | 25 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2005 | 16 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2011 | 501 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2005 | 54 | 0.020 |
Why?
|
| Denervation | 1 | 2005 | 29 | 0.020 |
Why?
|
| Emulsions | 1 | 2005 | 65 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2007 | 149 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 151 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 1161 | 0.020 |
Why?
|
| Histamine | 1 | 2005 | 44 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2005 | 61 | 0.020 |
Why?
|
| Graft Survival | 1 | 2007 | 525 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 258 | 0.020 |
Why?
|
| Tracheostomy | 1 | 2007 | 190 | 0.010 |
Why?
|
| Hemorheology | 1 | 2004 | 28 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 321 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2005 | 155 | 0.010 |
Why?
|
| Water | 1 | 2005 | 182 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 307 | 0.010 |
Why?
|
| Systole | 1 | 2004 | 196 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 169 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 213 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 697 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2826 | 0.010 |
Why?
|
| Yohimbine | 1 | 2002 | 18 | 0.010 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2002 | 8 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 450 | 0.010 |
Why?
|
| Tricuspid Atresia | 1 | 2002 | 14 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2002 | 40 | 0.010 |
Why?
|
| Symporters | 1 | 2002 | 66 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 577 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2003 | 206 | 0.010 |
Why?
|
| Glucose | 1 | 2005 | 872 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 957 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2002 | 495 | 0.010 |
Why?
|
| Synapses | 1 | 2002 | 449 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 4286 | 0.010 |
Why?
|